Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

January 24, 2017January 24, 2017

HOST Therabiomics Wants to Develop Dietary Compound into Bowel-disease Treatment

News

HOST Therabiomics hopes to develop the dietary compound HOST-G904, which improved the composition of gut bacteria without increasing gas, into a treatment for inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and other ... Read more

January 17, 2017

Infant IBD Patients Found to Get Well at Rate Similar to Older Children

News

A study of infants who developed inflammatory bowel disease (IBD) found that they recovered at a rate similar to patients who became ill later in childhood. IBD developing during a ... Read more

January 10, 2017

Simponi Seen to Show Promise as Short-Term Treatment for Ulcerative Colitis

News

An observational study of the TNF blocker Simponi (golimumab) in patients with ulcerative colitis found that it is a promising short-term treatment, but a large proportion of patients needed more of ... Read more

October 5, 2016

Entyvio’s Effect in IBD Continues After Years of Treatment

News

Takeda recently published interim data showing that Entyvio (vedolizumab) treatment continues to be beneficial for people with ulcerative colitis or Crohn’s disease, whether or not they were treated with TNF-blockers at an earlier date. ... Read more

July 25, 2016July 25, 2016

Online Survey Reveals Ulcerative Colitis Patients More Worried About Disease Complications Than Drug Side Effects

News, Ulcerative colitis

A survey to help in the development of a web-based, multimedia treatment decision aid for patients with ulcerative colitis showed that patients are more worried about complications of their disease than ... Read more

June 23, 2016June 23, 2016

Insight into IBD, Other Diseases May Be Gained by Knowledge of Innate and Adaptive Immune Systems

News

A view of the two parts of our immunity — the innate and adaptive immune systems — as two separate entities, with little or no communication between each other, was ... Read more

June 17, 2016June 17, 2016

IBD Crowdfunding at WellSpringboard to Explore Factors Predicting Flares

News

The University of Michigan has taken crowdfunding one step closer to its researchers and the general public. A platform called WellSpringboard allows the public to pitch research ideas, and once a U-M ... Read more

June 9, 2016August 12, 2016

IBD Study Shows Celltrion’s Inflectra, Biosimilar of Infliximab, Is Safe and Effective

Crohn's Disease, IBD News, News, Ulcerative colitis

Celltrion’s Inflectra, a biosimilar version of infliximab (Remicade), is both safe and effective in patients with inflammatory bowel disease (IBD), a recent study reported at the Digestive Disease Week 2016 meeting ... Read more

May 13, 2016May 13, 2016

Gene Mutations Can Stop Good Gut Bacteria from Easing Crohn’s Disease

Crohn's Disease, IBD News, News

Crohn’s disease patients with certain gene mutations may not benefit from normally helpful bacteria in their guts, new research published in the journal Science revealed. The new insights may alter ... Read more

May 6, 2016May 6, 2016

University of Toronto Scientist Awarded $2M to Study Environment’s Impact on IBD

News

A University of Toronto professor of immunology has received a $2 million grant for her research into environmental changes and autoimmune disease, such as inflammatory bowel disease (IBD), among South Asian Canadians. “Canada ... Read more